| RS34324114 |
NEK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Motor neuron disease, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS34324145 |
OSMR
|
Health Risk |
Conflicting classifications of pathogenicity |
OSMR-related disorder, OSMR-related disorder |
| RS34324426 |
PEX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Heimler syndrome 2, Peroxisome biogenesis disorder 4A (Zellweger) |
| RS34328787 |
SLC39A14
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS34330111 |
MYH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 14, Cardiovascular phenotype |
| RS34331388 |
GUCY2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS34336755 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS34337334 |
DES
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Desmin-related myofibrillar myopathy |
| RS34337578 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS34338233 |
PPP1R13L
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS34338935 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Inborn genetic diseases |
| RS34349517 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS34351119 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS34351171 |
SLC26A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Diastrophic dysplasia, Atelosteogenesis type II |
| RS34351746 |
LIPC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperlipidemia due to hepatic triglyceride lipase deficiency, Hyperlipidemia due to hepatic triglyceride lipase deficiency |
| RS34352773 |
DNAAF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 10 |
| RS34353618 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group A, Fanconi anemia |
| RS34355967 |
MAN1B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Rafiq syndrome, Rafiq syndrome |
| RS34360255 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica inversa |
| RS34361146 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome |
| RS34362143 |
C5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34363638 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS34364279 |
IGF1R
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34365303 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS34365964 |
FSHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 24 without anosmia, Hypogonadotropic hypogonadism 24 without anosmia |
| RS34367357 |
CARD14
|
Health Risk |
Benign/Likely benign; association |
Psoriasis 2, Pityriasis rubra pilaris |
| RS34371500 |
F8
|
Health Risk |
Pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS34371697 |
TOM1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34374110 |
CLDN19
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34374438 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS34378160 |
HBB
|
Health Risk |
Pathogenic |
HEMOGLOBIN HAMMERSMITH, HEMOGLOBIN CHIBA |
| RS34381515 |
LAMA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS34382952 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS34386532 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS34386552 |
CP
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of ferroxidase, Inborn genetic diseases |
| RS34387018 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS34387324 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spherocytosis, Hereditary spherocytosis type 1 |
| RS34388030 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome |
| RS34389000 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS34390308 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to DOCK8 deficiency, DOCK8-related disorder |
| RS34390834 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS34391522 |
ACOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital bile acid synthesis defect 6, ACOX2-related disorder |
| RS34391943 |
NPHP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Renal-hepatic-pancreatic dysplasia 1 |
| RS34393781 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS34395097 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS34396910 |
ADSL
|
Health Risk |
Conflicting classifications of pathogenicity |
Adenylosuccinate lyase deficiency, ADSL-related disorder |
| RS34406289 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Medulloblastoma, Gorlin syndrome |
| RS34412477 |
HSD3B2
|
Health Risk |
Conflicting classifications of pathogenicity |
3 beta-Hydroxysteroid dehydrogenase deficiency, HSD3B2-related disorder |
| RS34413183 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS34413634 |
HMBS
|
Health Risk |
Pathogenic |
Acute intermittent porphyria, Acute intermittent porphyria |
| RS34414438 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS34415446 |
CASQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS34415548 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS34424986 |
PRKN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive juvenile Parkinson disease 2, Young-onset Parkinson disease |
| RS34425379 |
ZNF423
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 14, Cervical cancer |
| RS34430836 |
HBD
|
Health Risk |
Pathogenic; other |
delta Thalassemia, HEMOGLOBIN A(2) GROVETOWN |
| RS34432586 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS34439278 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34439704 |
EIF2AK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial pulmonary capillary hemangiomatosis, Familial pulmonary capillary hemangiomatosis |
| RS34445293 |
PDGFRL
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34446260 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
HEMOGLOBIN HIKARI, HEMOGLOBIN HIKARI |
| RS34446466 |
RARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
RARS1-related disorder, Hypomyelinating leukodystrophy 9 |
| RS34446973 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyropoikilocytosis, hereditary |
| RS34447581 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Usher syndrome type 2A |
| RS34451549 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, Beta zero thalassemia |
| RS34457341 |
RIPK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 57, Immunodeficiency 57 |
| RS34457757 |
HAL
|
Health Risk |
association |
Increased histidine, Increased histidine |
| RS34460089 |
RBP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS34462126 |
HOXA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS34462132 |
FANCI
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group I |
| RS34464652 |
RNF43
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Sessile serrated polyposis cancer syndrome |
| RS34466953 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS34467829 |
BPNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Chondrodysplasia with joint dislocations, gPAPP type |
| RS34470310 |
STX11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 4, Inborn genetic diseases |
| RS34471100 |
RDX
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34471889 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS34472250 |
PNKP
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly, seizures |
| RS34474104 |
HBG2
|
Health Risk |
Likely pathogenic |
Cyanosis, transient neonatal |
| RS34474212 |
MC1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Melanoma, cutaneous malignant |
| RS34474955 |
EPCAM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 8 |
| RS34476949 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group A, Fanconi anemia |
| RS34477144 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 2, Autosomal dominant nonsyndromic hearing loss 11 |
| RS34477820 |
WRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Werner syndrome, Colon adenocarcinoma |
| RS34477959 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS34479952 |
SNTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS34480732 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS34482255 |
ITK
|
Health Risk |
Conflicting classifications of pathogenicity |
Lymphoproliferative syndrome 1, Autoinflammatory syndrome |
| RS34483965 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
beta Thalassemia, Beta-thalassemia HBB/LCRB |
| RS34484056 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
8 conditions, 8 conditions |
| RS34487290 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Inborn genetic diseases |
| RS34489989 |
TTC21B
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 12, Asphyxiating thoracic dystrophy 4 |
| RS34491822 |
ROR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Brachydactyly, type B1Robinow syndrome |
| RS34495017 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS34500389 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
beta Thalassemia, HBB-related disorder |
| RS34502690 |
HBB
|
Health Risk |
Pathogenic |
BETA-PLUS-THALASSEMIA, BETA-PLUS-THALASSEMIA |
| RS34504069 |
DPP3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34504204 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS34505698 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS34507711 |
MTFMT
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Combined oxidative phosphorylation defect type 15 |
| RS34509421 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |